PKC γ activators encompass a diverse group of compounds that share the ability to bind and activate protein kinase C gamma (PKC γ). The primary mechanism through which these activators operate involves interaction with the regulatory C1 domain of PKC γ, which is normally engaged by diacylglycerol (DAG) in physiological conditions. Upon binding to the C1 domain, these compounds facilitate the translocation of PKC γ to the plasma membrane, a requisite step for its activation. The range of structures within this class is broad, including natural products, like phorbol esters, to synthetic analogs of DAG. Phorbol esters, like PMA and PDBu, are the archetypes of PKC γ activators, with a well-established binding affinity for the C1 domain, triggering the activation cascade that results in PKC γ's full functionality.
Many of the activators are found in natural sources and have been studied extensively for their ability to activate PKC through binding to the C1 domain. Many synthetic analogs mirror the action of DAG, ensuring the activation of PKC γ through a mechanism that is akin to the natural activation process. The activation of PKC γ by these compounds is immediate and does not rely on secondary messenger systems, denoting a direct engagement and a subsequent effect on PKC γ's kinase activity. The structural diversity among PKC γ activPKC γ activators are a chemically diverse set of compounds that engage the protein kinase C gamma (PKC γ) isoform through various mechanisms, leading to its activation. Central to the function of these activators is their interaction with the regulatory C1 domain of PKC γ, which mirrors the action of diacylglycerol (DAG), the endogenous activator of PKC. The binding of these molecules to the C1 domain prompts a conformational change in PKC γ, facilitating its translocation to cellular membranes where it becomes fully active.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diester of phorbol and is known to mimic diacylglycerol (DAG), a physiological activator of PKC. It binds to the C1 domain of PKC γ, causing its activation. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DiC8 is a synthetic analog of DAG. It activates PKC γ by binding to the C1 domain and promoting its translocation to the plasma membrane. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 binds to the C1 domain of PKC γ, similar to DAG. It leads to PKC γ activation and subsequent translocation. | ||||||
Ingenol 3,20-dibenzoate | 59086-90-7 | sc-202663 sc-202663A sc-202663B sc-202663C | 1 mg 5 mg 10 mg 100 mg | $600.00 $2400.00 $3500.00 $24000.00 | 9 | |
This compound acts similarly to phorbol esters by binding to the C1 domain of PKC γ, leading to its activation. | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
PDBu is another phorbol ester that activates PKC γ by mimicking DAG and binding to the C1 domain. | ||||||
(−)-Indolactam V | 90365-57-4 | sc-202182 sc-202182A | 300 µg 1 mg | $175.00 $350.00 | 1 | |
This compound selectively activates PKC isozymes by binding to the C1 domain, thus activating PKC γ. | ||||||
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $141.00 $541.00 | 24 | |
Similar to other phorbol esters, prostratin binds to the C1 regulatory domain of PKC γ, activating the enzyme. | ||||||
1-Oleoyl-2-acetyl-sn-glycerol (OAG) | 86390-77-4 | sc-200417 sc-200417A | 10 mg 50 mg | $119.00 $453.00 | 1 | |
OAG is a synthetic DAG analogue that activates PKC γ by mimicking the action of natural DAG and binding to the C1 domain. | ||||||